RT Journal Article
SR Electronic
T1 779 A phase 1/2, open label, first-in-human, dose escalation and expansion study of SAR445877 administered as monotherapy in adults with advanced solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A876
OP A876
DO 10.1136/jitc-2023-SITC2023.0779
VO 11
IS Suppl 1
A1 Gutierrez, Martin
A1 Garralda, Elena
A1 Calvo, Emiliano
A1 Dongen, Marloes van
A1 Eskens, Ferry
A1 Finlay, Morgan
A1 Menas, Fatima
A1 Zhu, Chen
A1 Wu, Meijing
A1 Guillemin-Paveau, Helene
A1 Abbadessa, Giovanni
A1 Perez, Raymond
A1 Yildirim, Ozlem
A1 Naing, Aung
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A876.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.